Pharmaceutical application of a chemodenervating agent, particularly botulinum toxin, reduces inflammatory response and serves as an anti-inflammatory agent without systemic side effects and with long duration action, on the order of 12-24 weeks. In one embodiment, the effective dosage for allergy provoked...http://www.google.fr/patents/US7537773?utm_source=gb-gplus-shareBrevet US7537773 - Chemodenervating pharmaceutical as anti-inflammatory agent
Chemodenervating pharmaceutical as anti-inflammatory agent
